Global Commercial Lead, AskBio-1005, Parkinson's Disease

 

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where 'Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us. If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.

 

Global Commercial Lead, AskBio-1005, Parkinson's Disease 

 

Bayer is committed to delivering Health for All by advancing a portfolio of innovative treatments. The company has the passion and determination to develop and commercialize medicines that help improve patients’ lives. To position the company for the future, Bayer has significantly invested in new fields of R&D. One major area of innovation has been Cell & Gene Therapy (CGT), where we have driven rapid advances via the acquisition of two leading companies in this space, AskBio and BlueRock. With this investment, Bayer has rapidly built a broad pipeline of assets across a multitude of disease areas.

 

Our assets at the forefront of this pipeline have the potential to transform care for patients with Parkinson’s Disease (PD). AB-1005 (out of AskBio) is an investigational neurotrophic factor gene therapy with potential to reverse the degeneration of dopaminergic neurons. AB-1005 has been granted both Fast Track Designation and the Regenerative Medicine Advanced Therapy (RMAT) designation by the US Food & Drug Administration (FDA) to slow disease progression and improve motor outcomes in patients with PD. A randomized, double-blinded study is currently being conducted in the US, EU and UK.

 

Successful commercialization of this asset provides an exciting challenge as we enter this new and important therapeutic area, The cell therapy space brings additional complexities with advanced science, complex delivery & distribution models, as well as unique value propositions. This is a high-impact, high visibility role that requires an entrepreneurial mindset and a desire to challenge conventional approaches to ensure successful commercialization.

 

This is a key leadership position within the Global Product leadership Team. The Global Commercial Lead is responsible for shaping the global commercialization strategy for our first gene therapy asset in Parkinson’s Disease, partnering closely with AskBio colleagues, internal capability clusters, US Product Team, worldwide markets and key external stakeholders

 

YOUR TASKS AND RESPONSIBILITIES

 

The primary responsibilities of this role, Global Commercial Lead, AskBio-1005, Parkinson’s Disease, are to:

 

• As Visionary, Architect, Catalyst, and Coach provides leadership in defining commercial outcomes to ensure launch readiness;
• Key member of the AB-1005 Global Product Team working in partnership with peers to define and align the market entry strategy, brand strategy and key priorities;
• Leads commercialization sub-team and works in partnership with relevant colleagues to define and shape the outcomes and missions required to enable successful commercialization of the asset;
• Leads customer and market shaping, development of the patient journey and identifying the unmet need. Defines patient segmentation, awareness, and engagement strategy;
• Leads the development of global commercial vision and strategic priorities. Develops a winning market entry strategy and value proposition based on unmet customer needs to ensure patient access, reimbursement, and competitive pricing strategy in partnership with market access;
• Leads the co-creation of a winning Global Brand Strategy with market needs and business ambition in mind. Defines Target Segments, Positioning and Capability needs and supports development of data generation strategy to maximize brand ambition and patient outcomes;
• Leads the development of an innovative global GTM strategy working in partnership with key markets product supply and market access, recognizing the importance of an end-to-end value chain approach, working closely with PS to ensure cold chain manufacturing and logistics, and partnering market access on a distribution strategy, site procurement, site adoption, triaging of product modalities (components) and coding, coverage and reimbursement, for successful commercializatio